Aortic diseases encompass a spectrum of conditions affecting the aorta, the largest blood vessel in the body. The aorta plays a crucial role in transporting oxygenated blood from the heart to various organs. Conditions such as aortic aneurysms, dissections, and other structural abnormalities can pose serious health risks. Aortic diseases often require careful monitoring and, in some cases, prompt intervention to prevent complications. Advances in medical imaging and diagnostic techniques have significantly improved our ability to detect and manage aortic diseases, allowing for more personalized and effective treatment strategies. Research in this field continues to explore innovative approaches to better understand the underlying causes and develop targeted therapies, aiming to enhance patient outcomes and overall cardiovascular health. As our understanding of aortic diseases evolves, the collaboration between clinicians, researchers, and healthcare professionals becomes increasingly vital to address the complexities of these conditions and pave the way for improved patient care.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India